HomeURGN • NASDAQ
add
Urogen Pharma Ltd
Previous close
$11.55
Day range
$11.50 - $12.04
Year range
$10.60 - $20.70
Market cap
502.59M USD
Avg Volume
567.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 25.20M | 20.87% |
Operating expense | 40.30M | 25.98% |
Net income | -23.67M | -8.20% |
Net profit margin | -93.93 | 10.48% |
Earnings per share | -0.55 | 19.12% |
EBITDA | -17.48M | -31.27% |
Effective tax rate | -0.39% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 249.58M | 69.30% |
Total assets | 301.94M | 55.94% |
Total liabilities | 276.43M | 17.32% |
Total equity | 25.52M | — |
Shares outstanding | 42.20M | — |
Price to book | 19.25 | — |
Return on assets | -15.03% | — |
Return on capital | -31.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -23.67M | -8.20% |
Cash from operations | -27.66M | -59.92% |
Cash from investing | -106.75M | -26,720.95% |
Cash from financing | 39.61M | -65.88% |
Net change in cash | -94.81M | -195.59% |
Free cash flow | -18.10M | -83.24% |
About
Founded
2004
Headquarters
Website
Employees
217
